Zymfentra™ (infliximab-dyyb) – New drug approval
"October 23, 2023, - Celltrion announced the FDA approval of Zymfentra (infliximab-dyyb) in adults for maintenance treatment of:
- Moderately to severely active ulcerative colitis (UC) following treatment with an infliximab product administered intravenously (IV)
- Moderately to severely active Crohn’s disease (CD) following treatment with an infliximab product administered IV."
Top